These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 35786170)

  • 21. Key learnings from Institute for Clinical and Economic Review's real-world evidence reassessment pilot.
    Jaksa A; Bloudek L; Carlson JJ; Shah K; Chen Y; Patrick AR; McKenna A; Campbell JD
    Int J Technol Assess Health Care; 2022 Mar; 38(1):e32. PubMed ID: 35357284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices: A Landscape Assessment.
    Timbie JW; Kim AY; Concannon TW
    Value Health; 2021 Dec; 24(12):1792-1798. PubMed ID: 34838277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-World Evidence to Inform Regulatory Decision Making: A Scoping Review.
    Jansen MS; Dekkers OM; le Cessie S; Hooft L; Gardarsdottir H; de Boer A; Groenwold RHH
    Clin Pharmacol Ther; 2024 Jun; 115(6):1269-1276. PubMed ID: 38390633
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measuring the Effectiveness of Real-World Evidence to Ensure Appropriate Impact.
    Brown JP; Douglas IJ; Hanif S; Thwaites RMA; Bate A
    Value Health; 2021 Sep; 24(9):1241-1244. PubMed ID: 34452702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Healthcare Claims Data to Generate Real-World Evidence on Patients With Drug-Resistant Epilepsy: Practical Considerations for Research.
    Stamas N; Vincent T; Evans K; Li Q; Danielson V; Lassagne R; Berger A
    J Health Econ Outcomes Res; 2024; 11(1):57-66. PubMed ID: 38425708
    [No Abstract]   [Full Text] [Related]  

  • 26. HTA capacity building in Asia: towards one goal.
    Mundy L; Maddern G
    Int J Technol Assess Health Care; 2023 Aug; 39(1):e56. PubMed ID: 37581298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Real-world evidence generation from patients, their caregivers and physicians supporting clinical, regulatory and guideline decisions: an update on Disease Specific Programmes.
    Anderson P; Higgins V; Courcy J; Doslikova K; Davis VA; Karavali M; Piercy J
    Curr Med Res Opin; 2023 Dec; 39(12):1707-1715. PubMed ID: 37933204
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America.
    Justo N; Espinoza MA; Ratto B; Nicholson M; Rosselli D; Ovcinnikova O; García Martí S; Ferraz MB; Langsam M; Drummond MF
    Value Health; 2019 Jun; 22(6):739-749. PubMed ID: 31198192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A national evaluation analysis and expert interview study of real-world data sources for research and healthcare decision-making.
    Mikl V; Baltic D; Czypionka T; Degelsegger-Márquez A; Forgó N; Gouya-Lechner G; Herzog A; Klimek P; Lumenta DB; Mraz B; Ostermann H; Scharinger R; Stamm T; Strassnig M; Zeitlinger M; Pleiner-Duxneuner J
    Sci Rep; 2024 Apr; 14(1):9751. PubMed ID: 38679653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. "What's Keeping Me Up at Night?" Reflections on the COVID-19 Pandemic in Asia.
    Mundy L; Kearney B
    Int J Technol Assess Health Care; 2022 Jun; 38(1):e51. PubMed ID: 35702950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Comprehensive Framework for Evaluating the Value Created by Real-World Evidence for Diverse Stakeholders: The Case for Coordinated Registry Networks.
    Gressler LE; Marinac-Dabic D; Resnic FS; Williams S; Yang K; Weichold F; Avila-Tang E; Mack C; Coplan P; Panagiotou OA; Pappas G
    Ther Innov Regul Sci; 2024 Nov; 58(6):1042-1052. PubMed ID: 39060838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real-world evidence: experiences and challenges for decision making in Latin America.
    García Martí S; Pichón-Riviere A; Augustovski F; Espinoza M
    Int J Technol Assess Health Care; 2023 Dec; 39(1):e73. PubMed ID: 38108157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structure and Content of a Taxonomy to Support the Use of Real-World Evidence by Health Technology Assessment Practitioners and Healthcare Decision Makers.
    Murphy LA; Akehurst R; Solà-Morales O; Cunningham D; Mestre-Ferrandiz J; Franklin M; de Pouvourville G
    Value Health; 2023 Apr; 26(4S):20-31. PubMed ID: 36706951
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making.
    Berger ML; Sox H; Willke RJ; Brixner DL; Eichler HG; Goettsch W; Madigan D; Makady A; Schneeweiss S; Tarricone R; Wang SV; Watkins J; Daniel Mullins C
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1033-1039. PubMed ID: 28913966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health technology assessment. The pharmaceutical industry perspective.
    Schubert F
    Int J Technol Assess Health Care; 2002; 18(2):184-91. PubMed ID: 12053418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-world evidence to support Payer/HTA decisions about highly innovative technologies in the EU-actions for stakeholders.
    Facey KM; Rannanheimo P; Batchelor L; Borchardt M; de Cock J
    Int J Technol Assess Health Care; 2020 Sep; ():1-10. PubMed ID: 32878663
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advancing the development of real-world data for healthcare research in China: challenges and opportunities.
    Zhong J; Zhang J; Fang H; Liu L; Xie J; Wu E
    BMJ Open; 2022 Jul; 12(7):e063139. PubMed ID: 35906059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
    O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
    Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Review and Comparative Case Study Analysis of Real-World Evidence in European Regulatory and Health Technology Assessment Decision Making for Oncology Medicines.
    Zong J; Rojubally A; Pan X; Wolf B; Greenfeder S; Upton A; Gdovin Bergeson J
    Value Health; 2024 Oct; ():. PubMed ID: 39393564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.